IMP MULTI-YEAR TREND
Imexpharm Corporation — HSX
| Metric / CHỈ TIÊU | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | Change / BIẾN ĐỘNG |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets Tổng tài sản | 2,782,634,485 | 2,504,776,667 | 2,392,615,157 | 2,276,943,568 | — | — | — | — | — | — | — | — |
| Owner's Equity Vốn chủ sở hữu | 2,306,522,179 | 2,183,119,169 | 2,084,578,944 | 1,894,446,893 | — | — | — | — | — | — | — | — |
| Revenue Doanh thu | 2,914,294,074 | 2,512,786,047 | 2,113,869,796 | 1,676,311,518 | — | — | — | — | — | — | — | — |
| Net Profit After Tax Lợi nhuận sau thuế | 349,138,023 | 320,862,393 | 299,556,006 | 223,540,318 | — | — | — | — | — | — | — | — |
| ROE (%) Tỷ suất lợi nhuận trên VCSH | 15.14% | 14.70% | 14.37% | 11.80% | — | — | — | — | — | — | — | — |
| ROA (%) Tỷ suất lợi nhuận trên tài sản | 12.55% | 12.81% | 12.52% | 9.82% | — | — | — | — | — | — | — | — |
| Gross Margin (%) Biên lợi nhuận gộp | 34.37% | 34.05% | 38.34% | 41.60% | — | — | — | — | — | — | — | — |
| Net Margin (%) Biên lợi nhuận ròng | 11.98% | 12.77% | 14.17% | 13.34% | — | — | — | — | — | — | — | — |
| Debt/Equity Nợ/Vốn chủ sở hữu | 0.21% | 0.15% | 0.15% | 0.20% | — | — | — | — | — | — | — | — |